Welcome to our dedicated page for The Oncology Institute news (Ticker: $TOI), a resource for investors and traders seeking the latest updates and insights on The Oncology Institute stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The Oncology Institute's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The Oncology Institute's position in the market.
Rhea-AI Summary
WellBe Senior Medical strengthens its cancer care capabilities by partnering with The Oncology Institute, Inc. (NASDAQ: TOI) to offer High-Value Cancer Care Program to eligible patients in Illinois and Ohio. The program aims to provide personalized care management and supportive services to patients with active cancer diagnoses, resulting in improved patient satisfaction and reduced acute care facility utilization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. (TOI) has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill critical specialty medications and chemotherapeutics for MediCal patients, as well as provide medication fill capabilities to other patient populations. The new pharmacy location in the Los Angeles area aims to significantly expand TOI's oral drug business, addressing the cancer care costs of hundreds of thousands of MediCal patients. TOI has already lowered out-of-pocket costs for patients through its medically integrated dispensaries and expects to continue this trend with the new pharmacy location.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) reported financial results for Q3 2023, including a 26% revenue increase to $82 million and a net loss of $17.4 million. The company signed a full-risk capitated contract in South Florida and welcomed a new COO. TOI reaffirmed its full year 2023 guidance of $290 to $320 million in revenue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.72%
Tags
Rhea-AI Summary
The Oncology Institute, LLC to release Q3 2023 financial results and hold conference call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.82%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. appoints Jeremy Castle as Chief Operations Officer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
-
Rhea-AI Summary
TOI executives to participate in AVBCC Summit, focusing on value-based cancer care. Dr. Virnich to speak on topics including value-based agreements and reimbursement models. TOI subject matter experts to present on panels. Summit scheduled for October 18-20 in NYC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
Rhea-AI Summary
The Oncology Institute regains compliance with minimum bid price requirement, demonstrating strong revenue growth and forming technology partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
-
Rhea-AI Summary
Ambience Healthcare (AMBI), in collaboration with The Oncology Institute (TOI), has announced a groundbreaking agreement to implement a new AI operating system for oncology care. This partnership aims to address the challenges faced by oncologists in spending a significant amount of time in electronic health records (EHR) rather than with patients. Ambience Healthcare's generative AI technology will automate clinical documentation, allowing oncologists to focus on patient care. The platform will also provide personalized educational materials and care plans in real-time, tailored to patients' health literacy and language preferences. This agreement marks a significant advancement in the use of generative AI technology to enhance oncology care delivery in the United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.98%
Tags
-
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) reported its financial results for the second quarter of 2023, showing a 32% increase in revenue and an expansion of gross margin. The company also completed the acquisition of Southland Radiation Oncology Network and signed a new partnership with Massive Bio. TOI reaffirmed its full-year 2023 guidance and expects revenue growth of 15% to 27% over 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.98%
Tags
Rhea-AI Summary
The Oncology Institute (TOI) has entered into a multi-year relationship with House Rx to integrate their specialty medication dispensing model. This collaboration will expand patient access to oral specialty medications and enhance TOI's in-office dispensary operations. TOI aims to accelerate its clinic-based oral drug dispensing capabilities and add pharmacy locations in California and Texas. The partnership with House Rx is seen as a key driver of TOI's growth in the coming years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.83%
Tags
The Oncology Institute, Inc.
Nasdaq:TOI
TOI Rankings
TOI Stock Data
50.83M
32.81M
19.71%
57.52%
0.35%
Offices of Physicians (except Mental Health Specialists)
Health Care and Social Assistance
United States of America
CERRITOS
About TOI
the oncology institute of hope and innovation is a premier cancer treatment center in los angeles. offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, the oncology institute of hope and innovation has 8 southern california locations in the cities of downey, long beach, lynwood, montebello whittier, anaheim, la mirada and glendale. for more information please visit www.theoncologyinstitute.com.